APM
Avidity Partners Management Portfolio holdings
AUM
$439M
1-Year Est. Return
34.53%
1 Year Est. Return
+34.53%
AUM
$499M
AUM Growth
+$13.9M
(+2.9%)
Holding
80
Top Buys
| 1 | +$16.7M | |
| 2 | +$14.7M | |
| 3 | +$13.5M | |
| 4 |
CG Oncology
CGON
|
+$13.5M |
| 5 |
Genmab
GMAB
|
+$13.4M |
Top Sells
| 1 | +$16.1M | |
| 2 | +$13.2M | |
| 3 | +$13.1M | |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$9.93M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$9.48M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CG Oncology
CGON
$3.13B
| $39M | 7.77% |
1,499,942
+519,000
|
|
||
2
Boston Scientific
BSX
$152B
| $34.6M | 6.89% |
321,800
-14,200
|
|
||
3
Natera
NTRA
$28.2B
| $33.7M | 6.71% |
199,300
+80,100
|
|
||
4
Dianthus Therapeutics
DNTH
$1.75B
| $32.5M | 6.47% |
1,742,902
+22,000
|
|
||
5
Exact Sciences
EXAS
$12.7B
| $18.9M | 3.76% |
355,000
+2,000
|
|
||
6
Tenet Healthcare
THC
$17B
| $18.7M | 3.72% |
106,000
+34,000
|
|
||
7
DexCom
DXCM
$22.6B
| $18.4M | 3.66% |
210,500
+30,500
|
|
||
8
Danaher
DHR
$156B
| $17.7M | 3.53% |
89,700
+45,200
|
|
||
|
HNGE
9
Hinge Health
HNGE
$3.22B
| $16.7M | 3.32% |
+322,344
|
|
||
10
Intuitive Surgical
ISRG
$195B
| $14.7M | 2.93% |
+27,100
|
|
||
|
11
Genmab
GMAB
$18.6B
| $13.4M | 2.68% |
+650,000
|
|
||
12
Repligen
RGEN
$8.58B
| $13.2M | 2.64% |
+106,500
|
|
||
13
Thermo Fisher Scientific
TMO
$217B
| $12M | 2.39% |
29,600
+14,100
|
|
||
14
Teva Pharmaceuticals
TEVA
$29.2B
| $11.6M | 2.3% |
689,500
+208,500
|
|
||
|
JBIO
15
Jade Biosciences
JBIO
$492M
| $11.3M | 2.24% |
+1,127,186
|
|
||
16
Phathom Pharmaceuticals
PHAT
$1.04B
| $10.2M | 2.03% |
1,064,500
+264,500
|
|
||
17
UnitedHealth
UNH
$292B
| $9.98M | 1.99% |
32,000
-18,500
|
|
||
18
McKesson
MCK
$104B
| $9.89M | 1.97% |
+13,500
|
|
||
19
Axsome Therapeutics
AXSM
$7.04B
| $9.86M | 1.97% |
94,500
+17,500
|
|
||
20
Cencora
COR
$70.2B
| $9.84M | 1.96% |
32,800
-6,500
|
|
||
21
HealthEquity
HQY
$8.77B
| $9.64M | 1.92% |
92,000
+14,000
|
|
||
22
Encompass Health
EHC
$11.4B
| $9.07M | 1.81% |
+74,000
|
|
||
23
Revolution Medicines
RVMD
$13.1B
| $8.41M | 1.68% |
228,600
+15,600
|
|
||
24
Akero Therapeutics
AKRO
$4.47B
| $7.15M | 1.42% |
134,000
+77,000
|
|
||
|
OMDA
25
Omada Health Inc
OMDA
$1.16B
| $7.15M | 1.42% |
+390,600
|
|